ciprofloxacin hydrochloride; fluocinolone acetonide · Lab Salvat · NDA 208251
Otovel
Earliest generic entry, as listed
24 Mar 2030
Blocked by patent: US 8932610.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8932610 | product, use U-1578 | 24 Mar 2030 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 208251 · 001 · RLD | solution/drops, otic | EQ 0.3% BASE;0.025% | 24 Mar 2030 |